BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic...
Source: The Scientist - Category: Science Tags: The Scientist The Marketplace Source Type: news
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Grants | Infectious Diseases | Science | Small Businesses